TrialEndocrinology, diabetes & metabolism2025

Evaluating Intensive Insulin Therapy With Empagliflozin in Type 2 Diabetes: A Randomised Study.

Nobutoshi Fushimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.